← back to search

Weihang Peng

Guangzhou University of Chinese Medicine · CN
Area of research
Biological Psychiatry · Complementary and alternative medicine
Research interest
Research focused on Meta-analysis and Depression (economics), with related work in Angina, Decoction, Gene. Notable publications include 'Potential shared gene signatures and molecular mechanisms between atherosclerosis and depression: Evidence from transcriptome data', 'Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway', and 'Efficacy and Potential Mechanism of Chinese Herbal Formula Chaihu Shugan Powder on Animal Models of Depression: A Systematic Review and Meta‐Analysis'.
h-index
citations
27
works
8
NIH funding
primary concept
email

Recent publications

Efficacy and safety of guanxinshutong capsule as adjunctive therapy for unstable angina: an integrated systematic review, meta-analysis, and network pharmacology study
Frontiers in Cardiovascular Medicine 2026cited by 0position: middledoi
Corrigendum to “Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis” [J. Ethnopharmacol. (2025) 121096]
Journal of Ethnopharmacology 2026cited by 0position: middledoi
Efficacy and Potential Mechanism of Chinese Herbal Formula Chaihu Shugan Powder on Animal Models of Depression: A Systematic Review and Meta‐Analysis
CNS Neuroscience & Therapeutics 2025cited by 2position: middledoi
Uncovering the bidirectional molecular pathway: How shugan wendan decoction treats concurrent depression and atherosclerosis
Journal of Ethnopharmacology 2025cited by 0position: middledoi
Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway
Frontiers in Pharmacology 2024cited by 3position: middledoi
Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis
Frontiers in Pharmacology 2024cited by 2position: middledoi
Comprehensive effect of Naoxintong capsule combined with Western medicine on coronary heart disease after percutaneous coronary intervention: a meta-analysis
Frontiers in Pharmacology 2024cited by 2position: middledoi
Potential shared gene signatures and molecular mechanisms between atherosclerosis and depression: Evidence from transcriptome data
Computers in Biology and Medicine 2022cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Peiying Huang · Guangzhou University of Chinese Medicine6 papers (2022–2026)Liyuan Yu · Guangzhou University of Chinese Medicine5 papers (2022–2025)Lulu Wu · Fudan University4 papers (2024–2025)Yi‐Mo Deng · Guangzhou University of Chinese Medicine3 papers (2024–2025)Bojun Chen · Guangzhou University of Chinese Medicine3 papers (2024–2025)Meida Wang · Guangzhou University of Chinese Medicine3 papers (2024–2024)Yuchao Feng · Xijing Hospital3 papers (2022–2025)Li Chen · The Ohio State University2 papers (2024–2025)Bojun Chen · Guangzhou University of Chinese Medicine2 papers (2024–2026)Jing Zeng · Chinese PLA General Hospital2 papers (2024–2024)Zhishang Li · Guangzhou University of Chinese Medicine2 papers (2022–2024)Jiangsheng Lu · Guangzhou University of Chinese Medicine2 papers (2025–2026)Sisi Lei · Guangzhou University of Chinese Medicine2 papers (2022–2024)Ya Li · Guangzhou University of Chinese Medicine1 papers (2026–2026)Xiaohui Chen · Guangzhou University of Chinese Medicine1 papers (2026–2026)Hairong Cai · Guangzhou University of Chinese Medicine1 papers (2024–2024)Bojun Chen · Guangzhou University of Chinese Medicine1 papers (2022–2022)Li Yan · State Administration of Traditional Chinese Medicine of the People's Republic of China1 papers (2022–2022)Ye Ye · Guangzhou University of Chinese Medicine1 papers (2026–2026)Ya Li · Dalian Medical University1 papers (2025–2025)